Epistaxis resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 50: Line 50:
{{familytree | | | | | | | | | | A01 | | | | |A01=Patient with [[Epistaxis]] }}
{{familytree | | | | | | | | | | A01 | | | | |A01=Patient with [[Epistaxis]] }}
{{familytree | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | | A02 | | | | | |A02=Frist assess [['''ABC''']] }}
{{familytree | | | | | | | | | | A02 | | | | | |A02=First assess '''ABC'''* }}
{{familytree | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | | | | | A02 | | | | | |A02=Need of [[Immediate Action]]? }}
{{familytree | | | | | | | | | | A02 | | | | | |A02=Need of [[Immediate Action]]? }}
Line 69: Line 69:
{{familytree | | | F01 | | | | | | | | | | | | | F02 | | |F01=<div style="float: left; text-align: left; height: 7em; width: 14em; padding:1em;"> '''Risk factor Assessment :'''<br>
{{familytree | | | F01 | | | | | | | | | | | | | F02 | | |F01=<div style="float: left; text-align: left; height: 7em; width: 14em; padding:1em;"> '''Risk factor Assessment :'''<br>
----
----
❑ Assess [[HHT]]*  <br> ❑ Bilateral bleeding <br> ❑ [[Epistaxis]] history in Family  <br> </div>|F02=Bleeding site identified?}}
❑ Assess [[HHT]]**  <br> ❑ Bilateral bleeding <br> ❑ [[Epistaxis]] history in Family  <br> </div>|F02=Bleeding site identified?}}
{{familytree | | | |!| | | | | | | | | | | |,|-|-|^|-|-|.| | | }}
{{familytree | | | |!| | | | | | | | | | | |,|-|-|^|-|-|.| | | }}
{{familytree | | | | G01 | | | | | | | | G03 | | | | | G04 | | | | |G01=[[Rhinoscopy]] to identify location of [[bleeding]]| G03=<div style="float: left; text-align: left; height: 7em; width: 14em; padding:1em;"> '''Yes→ Three options:'''<br>
{{familytree | | | | G01 | | | | | | | | G03 | | | | | G04 | | | | |G01=[[Rhinoscopy]] to identify location of [[bleeding]]| G03=<div style="float: left; text-align: left; height: 7em; width: 14em; padding:1em;"> '''Yes→ Three options:'''<br>
Line 81: Line 81:
{{familytree | J01 | | J02 | |!| | | |`|-|-|-|^|-|-|-| J03 | | |J01=Bleeding controlled|J02=Bleeding resume|J03=[[Rist factor]] assessment}}
{{familytree | J01 | | J02 | |!| | | |`|-|-|-|^|-|-|-| J03 | | |J01=Bleeding controlled|J02=Bleeding resume|J03=[[Rist factor]] assessment}}
{{familytree | |!| | | |!| | |!| | | | | | | | | | | | |!| | | | | |}}
{{familytree | |!| | | |!| | |!| | | | | | | | | | | | |!| | | | | |}}
{{familytree | |!| | | |`|-|-| K02 | | | | | | | | | | K03 | |K01=K01|K02=Suspected Bleeding site HHT* or Anticoagulants?| K03=Patient education and prevention}}
{{familytree | |!| | | |`|-|-| K02 | | | | | | | | | | K03 | |K01=K01|K02=Suspected Bleeding site HHT** or Anticoagulants?| K03=Patient education and prevention}}
{{Familytree | |!| | | | | |,|-|-|^|-|-|.| | | | | | | |!| }}
{{Familytree | |!| | | | | |,|-|-|^|-|-|.| | | | | | | |!| }}
{{Familytree | |!| | | | | E01 | | | | E02 | | | | | | E03 | | | | | |E01=NO→[[Non absorbable]] or [[Absorbable packing]](Preferred in children)| E02=Yes→[[Absorbable packing]]| E03=Outcome Assesment}}
{{Familytree | |!| | | | | E01 | | | | E02 | | | | | | E03 | | | | | |E01=NO→[[Non absorbable]] or [[Absorbable packing]](Preferred in children)| E02=Yes→[[Absorbable packing]]| E03=Outcome Assesment}}
Line 104: Line 104:
{{Familytree | | | | | | | | |`|-|-|-|-| F01 |-|-| F02 |-|-| F03 | | | |F01=Patient Education and Prevention| F02=Outcome Assesment| F03=Discharge}}
{{Familytree | | | | | | | | |`|-|-|-|-| F01 |-|-| F02 |-|-| F03 | | | |F01=Patient Education and Prevention| F02=Outcome Assesment| F03=Discharge}}
{{familytree/end}}
{{familytree/end}}
*[[HHT]]= Hereditary Hemorrhagic Telangiecstasia
*ABC= Airway, Breathing, Circulation
**[[HHT]]= Hereditary Hemorrhagic Telangiecstasia


-This algorithm modified and developed according to Clinical Practice Nosebleed (Epistaxis) Guideline, This guideline was published in the January 2020 issue of the American Academy of Otolaryngology-Head and Neck Surgery.
-This algorithm modified and developed according to Clinical Practice Nosebleed (Epistaxis) Guideline, This guideline was published in the January 2020 issue of the American Academy of Otolaryngology-Head and Neck Surgery.

Revision as of 13:37, 14 August 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Synonyms and keywords:

Overview

Epistaxis also known as noes bleeding, is a terminology name for bleeding of nose vessels that drains out from nostril (most often) and/or nasopharynx. Epistaxis is often stop easily but sometimes it's an ENT emergency which can be critical if appropriate action does not occur. Kiesselbach's plexus is the source of most epistaxis.

Causes

Base on the cause and severity of Epistaxis it can be life threatening.

Life Threatening Causes

Life-threatening causes of epistaxis include conditions that may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Diagnosis

Shown below is an algorithm summarizing the diagnosis of Epistaxis according the the [...] guidelines.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Treatment

Shown below is an algorithm summarizing the treatment of [[Epistaxis]] according to The American Academy of ENT guidelines.

Statement Action Strength

 
 
 
 
 
 
 
 
 
Patient with Epistaxis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
First assess ABC*
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Need of Immediate Action?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes→ :

❑ Assess Airway
Hemodynamic stability
❑ Needs for emergency setting
 
 
 
 
 
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Active Bleeding ?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes→Nasal compression for≥5 min
 
 
 
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bleeding resume
 
Bleeding Controlled
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rhinoscopy to identify location of bleeding
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risk factor Assessment :

❑ Assess HHT**
❑ Bilateral bleeding
Epistaxis history in Family
 
 
 
 
 
 
 
 
 
 
 
 
Bleeding site identified?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rhinoscopy to identify location of bleeding
 
 
 
 
 
 
 
Yes→ Three options:

❑ 1=Lubricants
❑ 2=Topical vasoconstrictors
❑ 3=Nasal cautery
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bleeding site Identified
 
 
Bleeding site not identified
 
 
 
Decision for Nausal Cautery?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anestesia bleeding site and limit Nasal cautery to site
 
 
 
 
 
 
 
Yes→ Anestesia bleeding site and limit Nasal Cautery to site
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bleeding controlled
 
Bleeding resume
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rist factor assessment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Suspected Bleeding site HHT** or Anticoagulants?
 
 
 
 
 
 
 
 
 
Patient education and prevention
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO→Non absorbable or Absorbable packing(Preferred in children)
 
 
 
Yes→Absorbable packing
 
 
 
 
 
Outcome Assesment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nasal packing education
 
 
 
 
 
 
 
 
 
Discharge
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bleeding controlled
 
 
Bleeding resume
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient use Anticoagulant or Antiplatelet medications
 
 
Patient doesn't use Anticoagulant or Antiplatelet medications
 
 
 
 
 
 
 
 
 
 
 
Patient Education and prevention
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life treatening Nose bleeding?
 
 
 
 
 
 
 
 
 
 
Outcome Assement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes→ Evaluate need for or risk of discontinuation Anti-Coag/Anti-Platelet medications
 
No
 
 
 
 
 
 
 
Discharge
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bleeding controled
 
Bleeding resume
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluate candidency for Embolization or Surgical arterial ligation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appropriate intervention which may include Embolization, Surgery, Additional Nasal packing or Cautery
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient Education and Prevention
 
 
Outcome Assesment
 
 
Discharge
 
 
 
 
 
 
 
 
 
 
 
 
  • ABC= Airway, Breathing, Circulation
    • HHT= Hereditary Hemorrhagic Telangiecstasia

-This algorithm modified and developed according to Clinical Practice Nosebleed (Epistaxis) Guideline, This guideline was published in the January 2020 issue of the American Academy of Otolaryngology-Head and Neck Surgery.

Do's

  • The content in this section is in bullet points.

Don'ts

  • The content in this section is in bullet points.

References


Template:WikiDoc Sources